ScreenerHero
SANIONSaniona AB (publ)
STO · SE · Healthcare · Biotechnology · saniona.com
12.02SEK-4.30%Mkt Cap: 158.70M $P/E: 7.24

Saniona AB (publ), a clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, D…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap158.70M $
Enterprise Value114.94M $
Revenue (TTM)41.06M $
Gross Profit41.03M $
Net Income (TTM)27.23M $
Revenue/Share0.3036 USD
Last Price12.02 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees43
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)7.24
P/E (Forward)—
PEG—
EV/EBITDA5.04
EV/Revenue2.80
P/S3.83
P/B2.75
EPS (TTM)1.66
EPS (Forward)—
52W Range
8.03020% of range28.30
52W High28.30 SEK
52W Low8.030 SEK
Profitability
Gross Margin98.75%
Oper. Margin-1185.04%
EBITDA Margin55.52%
Profit Margin65.53%
ROE44.82%
ROA41.88%
Growth
Revenue Growth-52.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF26.19M $
CapEx (TTM)7.04M $
FCF Margin16.07%
FCF Yield4.16%
Net Debt-50.88M $
Net Debt/EBITDA-2.23
Balance Sheet
Debt/Equity0.00
Current Ratio10.55
Quick Ratio10.27
Book Value/Sh4.334 SEK
Cash/Share3.854 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)20.00 SEK
Upside (mean)+66.4%
Target Range20.00 SEK – 20.00 SEK
# Analysts1
Ownership
Shares Out.138.03M
Float121.34M
Insiders9.36%
Institutions24.29%
Technical
SMA 5013.14 (-8.5%)
SMA 20016.98 (-29.2%)
Beta1.22
S&P 52W Chg18.16%
Avg Vol (30d)330.35K
Avg Vol (10d)348.28K
Technical Indicators
RSI (14)38.8
MACD-0.1454
MACD Signal-0.0093
MACD Hist.-0.1362
BB Upper14.37 SEK
BB Middle13.36 SEK
BB Lower12.35 SEK
BB Width15.17%
ATR (14)0.5015 SEK
Vol Ratio (20d)0.80x